Schön, Michael P <br/><br/>
Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety.  [electronic resource] 

 -  Clinics in dermatology   
 - 509-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0738-081X 
<br/><br/><label>Standard No.: </label>10.1016/j.clindermatol.2007.10.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>CD11a Antigen--immunology<br/>Humans<br/>Psoriasis--drug therapy